These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 7529034)
21. Human antibodies responsible for binding inhibition and polymerization inhibition of human immunodeficiency virus type 1 reverse transcriptase. Odawara F; Sano K; Otake T; Okubo S; Nakano T; Takasaki T; Ueba N; Misaki H; Nakai M J Immunol Methods; 1996 Dec; 199(2):175-84. PubMed ID: 8982360 [TBL] [Abstract][Full Text] [Related]
22. Allosteric inhibition of human immunodeficiency virus type 1 reverse transcriptase by tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione compounds. Debyser Z; Pauwels R; Andries K; Desmyter J; Engelborghs Y; Janssen PA; De Clercq E Mol Pharmacol; 1992 Jan; 41(1):203-8. PubMed ID: 1370707 [TBL] [Abstract][Full Text] [Related]
23. Role of methionine 184 of human immunodeficiency virus type-1 reverse transcriptase in the polymerase function and fidelity of DNA synthesis. Pandey VN; Kaushik N; Rege N; Sarafianos SG; Yadav PN; Modak MJ Biochemistry; 1996 Feb; 35(7):2168-79. PubMed ID: 8652558 [TBL] [Abstract][Full Text] [Related]
24. Studies on primer binding of HIV-1 reverse transcriptase using a fluorescent probe. Delahunty MD; Wilson SH; Karpel RL J Mol Biol; 1994 Feb; 236(2):469-79. PubMed ID: 7508989 [TBL] [Abstract][Full Text] [Related]
25. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. Tantillo C; Ding J; Jacobo-Molina A; Nanni RG; Boyer PL; Hughes SH; Pauwels R; Andries K; Janssen PA; Arnold E J Mol Biol; 1994 Oct; 243(3):369-87. PubMed ID: 7525966 [TBL] [Abstract][Full Text] [Related]
26. Peyssonols A and B, two novel inhibitors of the reverse transcriptases of human immunodeficiency virus types 1 and 2. Loya S; Bakhanashvili M; Kashman Y; Hizi A Arch Biochem Biophys; 1995 Feb; 316(2):789-96. PubMed ID: 7532386 [TBL] [Abstract][Full Text] [Related]
27. Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC. Krebs R; Immendörfer U; Thrall SH; Wöhrl BM; Goody RS Biochemistry; 1997 Aug; 36(33):10292-300. PubMed ID: 9254628 [TBL] [Abstract][Full Text] [Related]
28. Partial selective inhibition of HIV-1 reverse transcriptase and human DNA polymerases γ and β by thiated 3'-fluorothymidine analogue 5'-triphosphates. Wińska P; Miazga A; Poznański J; Kulikowski T Antiviral Res; 2010 Nov; 88(2):176-81. PubMed ID: 20739003 [TBL] [Abstract][Full Text] [Related]
29. Recombinant polypeptides from the human immunodeficiency virus reverse transcriptase define three epitopes recognized by antibodies in sera from patients with acquired immunodeficiency syndrome. Padberg C; Nowlan S; Mermer B AIDS Res Hum Retroviruses; 1989 Feb; 5(1):61-71. PubMed ID: 2470400 [TBL] [Abstract][Full Text] [Related]
30. Inactivation of human immunodeficiency virus type 1 reverse transcriptase by oltipraz: evidence for the formation of a stable adduct. Chavan SJ; Bornmann WG; Flexner C; Prochaska HJ Arch Biochem Biophys; 1995 Dec; 324(1):143-52. PubMed ID: 7503549 [TBL] [Abstract][Full Text] [Related]
31. Regulation of the reverse transcriptase of human immunodeficiency virus type 1 by dNTPs. West AB; Roberts TM; Kolodner RD Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9720-4. PubMed ID: 1384060 [TBL] [Abstract][Full Text] [Related]
32. Mechanism of inhibition of HIV-1 reverse transcriptase by the novel broad-range DNA polymerase inhibitor N-{2-[4-(aminosulfonyl)phenyl]ethyl}-2-(2-thienyl)acetamide. Herschhorn A; Oz-Gleenberg I; Hizi A Biochemistry; 2008 Jan; 47(1):490-502. PubMed ID: 18052256 [TBL] [Abstract][Full Text] [Related]
33. Generation and characterization of murine monoclonal antibodies reactive against N-terminal and other regions of HIV-1 reverse transcriptase. Li X; Amandoron E; Wainberg MA; Parniak MA J Med Virol; 1993 Mar; 39(3):251-9. PubMed ID: 7682257 [TBL] [Abstract][Full Text] [Related]
35. Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase. Fan N; Rank KB; Poppe SM; Tarpley WG; Sharma SK Biochemistry; 1996 Feb; 35(6):1911-7. PubMed ID: 8639674 [TBL] [Abstract][Full Text] [Related]
36. Steady-state kinetic studies with the polysulfonate U-9843, an HIV reverse transcriptase inhibitor. Althaus IW; Chou JJ; Gonzales AJ; LeMay RJ; Deibel MR; Chou KC; Kezdy FJ; Romero DL; Thomas RC; Aristoff PA Experientia; 1994 Jan; 50(1):23-8. PubMed ID: 7507441 [TBL] [Abstract][Full Text] [Related]
37. A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradation. Fan N; Rank KB; Slade DE; Poppe SM; Evans DB; Kopta LA; Olmsted RA; Thomas RC; Tarpley WG; Sharma SK Biochemistry; 1996 Jul; 35(30):9737-45. PubMed ID: 8703945 [TBL] [Abstract][Full Text] [Related]
38. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors. Auwerx J; Esnouf R; De Clercq E; Balzarini J Mol Pharmacol; 2004 Jan; 65(1):244-51. PubMed ID: 14722257 [TBL] [Abstract][Full Text] [Related]
39. [Polymerase and immunologic activity of reverse transcriptase of the HIV-1 virus, isolated from Escherichia coli]. Shvetsov IuP; Mel'nikov AA; Suvorova ZK; Kopylova-Sviridova TN; Pokrovskiĭ VV; Fodor II Mol Gen Mikrobiol Virusol; 1991 Mar; (3):22-4. PubMed ID: 1713297 [TBL] [Abstract][Full Text] [Related]